Boston Scientific's (NYSE:BSX) Returns Have Hit A Wall
Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Ventyx Biosciences (VTYX)
Needham Reiterates Hold on Boston Scientific
Boston Scientific Analyst Ratings
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors
International Expansion Supports BSX Stock Amid Macroeconomic Woes
BSX Stock Set to Gain From Agreement to Acquire Intera Oncology
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Boston Scientific Shares Positive Acurate Prime XL TAVR Data
Express News | Boston Scientific Corp: Specific Terms of Transaction Have Not Been Disclosed
Express News | Boston Scientific Corp - Transaction Expected to Be Dilutive on Gaap Basis in 2025
Express News | Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
Press Release: Boston Scientific Announces Agreement to Acquire Intera Oncology(R) Inc.
Boston Scientific Announces Agreement to Acquire Intera Oncology Inc.
Boston Scientific Insider Sold Shares Worth $446,902, According to a Recent SEC Filing
Boston Scientific Launches 2025 Incentive Programs
Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report?
Boston Scientific (NYSE:BSX) Jumps 4.5% This Week, Though Earnings Growth Is Still Tracking Behind Three-year Shareholder Returns